CAR (Chimeric Antigen Receptor) T-cell therapy is an immunotherapy approach entailing the modification of a patient's immune cells to enhance their ability to recognize and attack cancerous cells. In India, this avant-garde treatment has been hailed as a transformative force in the struggle against hematologic malignancies such as leukemia and lymphoma. Clinical trials have showcased remarkable response rates among patients undergoing CAR T cell therapy, with many achieving complete remission or protracted disease control, even in instances of relapsed or refractory cancer.
read more..